Entering text into the input field will update the search result below

More on Aquinox Pharma Q2 results

Aug. 11, 2014 7:20 PM ETNeurogene Inc. (NGNE) StockBy: Douglas W. House, SA News Editor
  • Aquinox Pharmaceuticals (AQXP +2.2%) Q2 results: Revenues: $0M, Net Loss: ($5.4M) (-558.5%); Quick Assets: $35.9M (+160.1%).
  • No financial guidance given.

Recommended For You

More Trending News

About NGNE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NGNE--
Neurogene Inc.